Dr. Latif is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3025 Kate Bond Rd
Bartlett, TN 38133Phone+1 901-384-0065Fax+1 901-266-1165
Education & Training
University of TennesseeFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002- University of TennesseeResidency, Internal Medicine, 1992 - 1995
Aga Khan Medical CollegeClass of 1990
Certifications & Licensure
TN State Medical License 1995 - 2025
MS State Medical License 2024 - 2024
Publications & Presentations
PubMed
- 6 citationsSafety and Glycemic Outcomes During the MiniMedAdvanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.Catherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, Kevin B Kaiserman, Jennifer L Sherr
Diabetes Technology & Therapeutics. 2023-11-01 - 13 citationsEvaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.Ron Brazg, Satish K Garg, Anuj Bhargava, James R Thrasher, Kashif Latif
Diabetes Technology & Therapeutics. 2022-08-01 - 140 citationsEfficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.Guillermo E. Umpierrez, Kashif A. Latif, James Stoever, Ruben Cuervo, Linda Park
The American Journal of Medicine. 2004-09-01
Press Mentions
Senseonics Holdings, Inc. Announces Data from the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for DiabetesMarch 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
